Articles of the following types are accepted by the Editors：
Original articles are full-length reports of original research. Articles cover topics relevant to clinical, translational, basic and public health studies in the field of hepatology. To be published, the work presented in the manuscript must be original; on occasion, confirmatory studies of timely and important observations will also be acceptable. Original articles must be no longer than 4,000 words (including references, table/figure legends). Structured abstracts of up to 250 words are required, structured as follows: background and aims; methods; results; conclusion. The title should with no more than 120 characters (excluding spaces). Manuscripts should contain no more than 8 figures and tables. References should not exceed a maximum of 100.
Review articles on selected clinical and basic topics of interest for the readers of the iLIVER that are solicited by the Editors. Key aims of Reviews are to provide systematic and substantial coverage of mature subjects, evaluations of progress in specified areas, and/or critical assessments of emerging technologies. Review articles are expected to be clear, concise and updated, also should include 3 to 6 key points that briefly summarize or highlight the main content of the article. Review articles should be no longer than 7,000 words (excluding references). Unstructured abstracts of up to 250 words are required. The inclusion of a maximum of 8 tables and/or figures to summarize critical points is allowed. References should not exceed a maximum of 150.
Meta-analysis articles are systematic, critical assessments of current literature pertaining to clinical topics, emphasizing factors such as cause, diagnosis, prognosis, therapy, or prevention. All articles should be searched for and selected systematically for inclusion and critically evaluated, and the search and selection process should be described in the manuscript. The specific type of study or analysis should be described for each article or data source. We encourage authors of meta-analyses of clinical trials to submitted the PRISMA flow diagram and checklist. Authors of meta-analyses of observational studies are encouraged to submit the MOOSE checklist. The PRISMA and MOOSE items should be designated as supplemental digital content items. Word and reference limits: Text: 5,000 words, excluding abstract, references, tables, and figures; Abstract: 250 words; References: 75 maximum. A maximum combined number of 7 tables & figures may be included for publication in print. Additional tables and figures may be included as online-only supplemental data content published in print and online.
Short communications are concise, meritorious scientific reports of novel original research that is within the journal's scope and of particular interest to the community, but not suitable as a standard research article. It should not have an abstract or subsections such as Introduction, Results or Discussion. In principal, the information of Materials and Methods is not needed. However, when such information is important to the study, it could be submitted as supplementary materials. Short communications must be no longer than 1,000 words (excluding table/figure legends, or references). Manuscripts should contain no more than 1 figure or table and 10 references. The maximum number of authors is 6. Short communications with a higher number of authors will be reclassified as original articles.
Editorials are opinions of recognized leaders in hepatobiliary specialties. They are invited by the Editor, Deputy Editor, or Associate Editors and should be no longer than 1,500 words (including references and table or figure legends) and include no more than 1 figure or table and 9 references in addition to the paper being discussed.
Correspondence allows the opportunity to offer novel perspectives and opinions on full-length original research articles and short communications published in iLIVER. Correspondence must be submitted for consideration by the end of the month in which the corresponding article was published in print (e.g., a response to an article in the March issue should be submitted by the end of March). Correspondence is usually not peer reviewed and will be considered at the discretion of the editor. The journal might invite replies from the authors of the original publication. The accepted correspondence may be edited for clarity or length and proofs will be sent out to authors before publication. Correspondence should be no longer than 500 words (including references and table or figure legends) and include no more than 5 references and 1 figure or table. The maximum number of authors is 2.
Consensus and Practice Guideline should be driven by a high level of evidence and describe novel diagnostic or therapeutic algorithms that are not already well-documented by other organizations or publications. Consensus meetings or Guideline committees should be convened by a high-profile, non-profit, Hepatology organization or group that ensures broad and objective input from recognized experts on the topic. The length of Practice Guideline is decided by the Editor on a case-by-case basis. Consensus should be no longer than 2,400 words (including figure/ table legends) and contain no more than 2 figures or tables and 25 references.
